4//SEC Filing
Seth Kiernan 4
Accession 0001127602-22-004765
CIK 0001062822other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:09 PM ET
Size
7.7 KB
Accession
0001127602-22-004765
Insider Transaction Report
Form 4
Seth Kiernan
VP, Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-10+206,670→ 206,670 totalExercise: $3.20Exp: 2032-02-10→ Common Stock (206,670 underlying) - Award
Restricted Stock Units
2022-02-10+68,890→ 68,890 total→ Common Stock (68,890 underlying)
Footnotes (3)
- [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001890439
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:09 PM ET
- Size
- 7.7 KB